Can-Fite BioPharma Ltd. Cash And Cash Equivalents
Can-Fite BioPharma Ltd. (CANF) had Cash And Cash Equivalents of $2.70 million as of 2019-12-31, per its 20-F filed 2020-03-27.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
ifrs-full:CashAndCashEquivalents · last filed 2020-03-27
- 2019-12-31: Cash And Cash Equivalents $2.70M.
- 2019-06-30: Cash And Cash Equivalents $8.20M.
- 2018-12-31: Cash And Cash Equivalents $3.62M.
- 2018-06-30: Cash And Cash Equivalents $5.84M.
| Period end | Cash And Cash Equivalents | Cash And Cash Equivalents as first filed |
|---|---|---|
| 2019-12-31 | $2.70M 20-F · filed 2020-03-27 | |
| 2019-06-30 | $8.20M 6-K · filed 2019-08-30 | |
| 2018-12-31 | $3.62M 20-F · filed 2020-03-27 | |
| 2018-06-30 | $5.84M 6-K · filed 2019-08-30 | |
| 2017-12-31 | $3.50M 20-F · filed 2020-03-27 | $3.51M 20-F · filed 2018-03-28 |
| 2017-06-30 | $6.86M 6-K · filed 2018-08-31 | |
| 2016-12-31 | $8.12M 20-F · filed 2020-03-27 | $9.00M 20-F · filed 2018-03-28 |
| 2015-12-31 | $16.92M 20-F · filed 2019-03-29 | |
| 2014-12-31 | $9.28M 6-K · filed 2018-08-08 |